Skip to main content

Great Debates & Updates in Lung Cancers Main banner

Session VII: Immune Checkpoint Inhibitors for NSCLC

Debate: Adjuvant vs Neoadjuvant CPIs in Resectable NSCLC? - Discussion

Thursday, August 25, 2022

2:34 PM – 2:40 PM

Panelist(s)

Jamie E. Chaft, MD

Memorial Sloan Kettering Cancer Center
Joel W. Neal, MD, PhD

Stanford University Medical Center